Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Eur J Radiol ; 149: 110226, 2022 Apr.
Article in English | MEDLINE | ID: mdl-35231806

ABSTRACT

PURPOSE: To investigate radiomics and machine learning (ML) as possible tools to enhance MRI-based risk stratification in patients with endometrial cancer (EC). METHOD: From two institutions, 133 patients (Institution1 = 104 and Institution2 = 29) with EC and pre-operative MRI were retrospectively enrolled and divided in two a low-risk and a high-risk group according to EC stage and grade. T2-weighted (T2w) images were three-dimensionally annotated to obtain volumes of interest of the entire tumor. A PyRadiomics based and previously validated pipeline was used to extract radiomics features and perform feature selection. In particular, feature stability, variance and pairwise correlation were analyzed. Then, the least absolute shrinkage and selection operator technique and recursive feature elimination were used to obtain the final feature set. The performance of a Support Vector Machine (SVM) algorithm was assessed on the dataset from Institution 1 via 2-fold cross-validation. Then, the model was trained on the entire Institution 1 dataset and tested on the external test set from Institution 2. RESULTS: In total, 1197 radiomics features were extracted. After the exclusion of unstable, low variance and intercorrelated features least absolute shrinkage and selection operator and recursive feature elimination identified 4 features that were used to build the predictive ML model. It obtained an accuracy of 0.71 and 0.72 in the train and test sets respectively. CONCLUSIONS: Whole-lesion T2w-derived radiomics showed encouraging results and good generalizability for the identification of low-risk EC patients.


Subject(s)
Endometrial Neoplasms , Magnetic Resonance Imaging , Endometrial Neoplasms/diagnostic imaging , Female , Humans , Machine Learning , Magnetic Resonance Imaging/methods , Retrospective Studies , Risk Assessment
2.
Acad Radiol ; 28(5): 737-744, 2021 05.
Article in English | MEDLINE | ID: mdl-32229081

ABSTRACT

RATIONALE AND OBJECTIVES: To evaluate an MRI radiomics-powered machine learning (ML) model's performance for the identification of deep myometrial invasion (DMI) in endometrial cancer (EC) patients and explore its clinical applicability. MATERIALS AND METHODS: Preoperative MRI scans of EC patients were retrospectively selected. Three radiologists performed whole-lesion segmentation on T2-weighted images for feature extraction. Feature robustness was tested before randomly splitting the population in training and test sets (80/20% proportion). A multistep feature selection was applied to the first, excluding noninformative, low variance features and redundant, highly-intercorrelated ones. A Random Forest wrapper was used to identify the most informative among the remaining. An ensemble of J48 decision trees was tuned and finalized in the training set using 10-fold cross-validation, and then assessed on the test set. A radiologist evaluated all MRI scans without and with the aid of ML to detect the presence of DMI. McNemars's test was employed to compare the two readings. RESULTS: Of the 54 patients included, 17 had DMI. In all, 1132 features were extracted. After feature selection, the Random Forest wrapper identified the three most informative which were used for ML training. The classifier reached an accuracy of 86% and 91% and areas under the Receiver Operating Characteristic curve of 0.92 and 0.94 in the cross-validation and final testing, respectively. The radiologist performance increased from 82% to 100% when using ML (p = 0.48). CONCLUSION: We proved the feasibility of a radiomics-powered ML model for DMI detection on MR T2-w images that might help radiologists to increase their performance.


Subject(s)
Endometrial Neoplasms , Magnetic Resonance Imaging , Endometrial Neoplasms/diagnostic imaging , Female , Humans , Machine Learning , Pilot Projects , Retrospective Studies
3.
Mediators Inflamm ; 2013: 971758, 2013.
Article in English | MEDLINE | ID: mdl-24288446

ABSTRACT

Cystoid macular oedema (CMO) is a major cause of reduced vision following intraocular surgery. Although the aetiology of CMO is not completely clarified, intraocular inflammation is known to play a major role in its development. The macula may develop cytotoxic oedema when the primary lesion and fluid accumulation occur in the parenchymatous cells (intracellular oedema) or vasogenic oedema when the primary defect occurs in the blood-retinal barrier and leads to extracellular fluid accumulation (extracellular oedema). We report on the mechanisms of CMO formation after pars plana vitrectomy and associated surgical procedures and discuss possible therapeutic approaches.


Subject(s)
Inflammation/pathology , Macular Edema/etiology , Macular Edema/immunology , Vitrectomy/adverse effects , Anti-Inflammatory Agents, Non-Steroidal/therapeutic use , Blood-Retinal Barrier , Cataract Extraction/adverse effects , Humans , Lens, Crystalline/surgery , Macular Edema/prevention & control , Retina/surgery , Silicones/chemistry , Uveitis/surgery
SELECTION OF CITATIONS
SEARCH DETAIL
...